VRCA Verrica Pharmaceuticals Inc.

NASDAQ
$2.88

Verrica Pharmaceuticals Inc. (VRCA) Earnings News

Earnings press releases, previews and reviews for Verrica Pharmaceuticals Inc. (VRCA), newest first. Our most recent is review: Verrica Misses on EPS as Record YCANTH Sales Rest on Pricing Yield, Not Volume, and the Cash Runway Shrinks.